What this study is
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.
Study details
- Sponsor
- Massachusetts General Hospital
- Conditions
- Pregnant Women · Psychotropic Drugs
- Enrolling
- 5,000 people
- Starts
- 2008-11
- Est. completion
- 2033-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 45 YearsSex FEMALEHealthy volunteers AcceptedYou may qualify if
- Pregnant women
- Age 18-45
- Subjects will be willing to participate over the phone
- Subjects will be able to provide informed consent
You can't join if
- Women who have completed their pregnancy
- Women who are planning to become pregnant
- Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMassachusetts General Hospital
Boston, Massachusetts, United States
- Bryn Rediger, BA · Contact(617) 724-8020admin@womensmentalhealth.org
- Lee Cohen, MD · Principal investigator
Recruiting
Study team
Sponsor
Massachusetts General Hospital
Study ID 2008P-001861
Principal investigator
Lee S Cohen, MD
Massachusetts General Hospital
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.